362 related articles for article (PubMed ID: 30813164)
1. Risk factors of thromboembolism in nonvalvular atrial fibrillation patients with low CHA2DS2-VASc score.
Yan S; Li Q; Xia Z; Yan S; Wei Y; Hong K; Wu Y; Li J; Cheng X
Medicine (Baltimore); 2019 Feb; 98(8):e14549. PubMed ID: 30813164
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of lipoprotein(a) for left atrial thrombus or spontaneous echo contrast in non-valvular atrial fibrillation patients with low CHA
Kamili K; Zheng T; Luo C; Wang X; Tian G
Lipids Health Dis; 2024 Jan; 23(1):22. PubMed ID: 38254171
[TBL] [Abstract][Full Text] [Related]
3. Effect of Metabolic Syndrome on Risk Stratification for Left Atrial or Left Atrial Appendage Thrombus Formation in Patients with Nonvalvular Atrial Fibrillation.
Chen YY; Liu Q; Liu L; Shu XR; Su ZZ; Zhang HF; Nie RQ; Wang JF; Xie SL
Chin Med J (Engl); 2016 Oct; 129(20):2395-2402. PubMed ID: 27748329
[TBL] [Abstract][Full Text] [Related]
4. The value of urine albumin in predicting thromboembolic events for patients with non-valvular atrial fibrillation.
He H; Guo J; Zhang A
Int J Cardiol; 2016 Oct; 221():827-30. PubMed ID: 27434352
[TBL] [Abstract][Full Text] [Related]
5. Value of left atrial diameter with CHA2DS2-VASc score in predicting left atrial/left atrial appendage thrombosis in non-valvular atrial fibrillation.
Zhang Y; Yuan YQ
Arq Bras Cardiol; 2021 Feb; 116(2):325-331. PubMed ID: 33470330
[TBL] [Abstract][Full Text] [Related]
6. Predicting a decrease in left atrial appendage flow velocity using left atrial diameter and CHA
Wang G; Li G; Hu F; Zang M; Pu J
BMC Cardiovasc Disord; 2023 Apr; 23(1):180. PubMed ID: 37013469
[TBL] [Abstract][Full Text] [Related]
7. Comparison between CHADS2 and CHA2DS2-VASc score for risk stratification of ischemic stroke in Japanese patients with non-valvular paroxysmal atrial fibrillation not receiving anticoagulant therapy.
Komatsu T; Sato Y; Ozawa M; Kunugita F; Yoshizawa R; Morino Y; Nakamura M
Int Heart J; 2014; 55(2):119-25. PubMed ID: 24632957
[TBL] [Abstract][Full Text] [Related]
8. CHADS2 and CHA2DS2-VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation.
Letsas KP; Efremidis M; Giannopoulos G; Deftereos S; Lioni L; Korantzopoulos P; Vlachos K; Xydonas S; Kossyvakis C; Sideris A
Europace; 2014 Feb; 16(2):202-7. PubMed ID: 23813452
[TBL] [Abstract][Full Text] [Related]
9. Enhancing the evaluation of acute ischemic stroke risk in individuals with non-valvular atrial fibrillation by including laboratory indicators.
Hou X; Zhang X
Sci Rep; 2024 Mar; 14(1):6844. PubMed ID: 38514850
[TBL] [Abstract][Full Text] [Related]
10. Association of the CHA2DS2-VASc score with left atrial spontaneous echo contrast: a cross-sectional study of patients with rheumatic mitral stenosis in sinus rhythm.
Belen E; Ozal E; Pusuroglu H
Heart Vessels; 2016 Sep; 31(9):1537-43. PubMed ID: 26475711
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for left atrial thrombus or spontaneous echo contrast in non-valvular atrial fibrillation patients with low CHA
Chen J; Zhou M; Wang H; Zheng Z; Rong W; He B; Zhao L
J Thromb Thrombolysis; 2022 Feb; 53(2):523-531. PubMed ID: 34476733
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of CHADS2 versus CHA2DS2-VASc for predicting stroke and thromboembolism in atrial fibrillation patients independent of anticoagulation.
Zhu WG; Xiong QM; Hong K
Tex Heart Inst J; 2015 Feb; 42(1):6-15. PubMed ID: 25873792
[TBL] [Abstract][Full Text] [Related]
13. [Independent risk factors of atrial thrombosis in patients with nonvalvular atrial fibrillation and low CHA
Zhou M; Chen J; Wang H; Xi S; Gan T; Zhao L
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Aug; 41(8):1243-1249. PubMed ID: 34549717
[TBL] [Abstract][Full Text] [Related]
14. CHADS
Wu JT; Wang SL; Chu YJ; Long DY; Dong JZ; Fan XW; Yang HT; Duan HY; Yan LJ; Qian P
J Atheroscler Thromb; 2017 Feb; 24(2):176-184. PubMed ID: 27301462
[TBL] [Abstract][Full Text] [Related]
15. CHA
D'Souza M; Carlson N; Fosbøl E; Lamberts M; Smedegaard L; Nielsen D; Torp-Pedersen C; Gislason G; Schou M
Eur J Prev Cardiol; 2018 Apr; 25(6):651-658. PubMed ID: 29482441
[TBL] [Abstract][Full Text] [Related]
16. Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation.
Tu HT; Campbell BC; Meretoja A; Churilov L; Lees KR; Donnan GA; Davis SM
Cerebrovasc Dis; 2013; 36(4):273-80. PubMed ID: 24135809
[TBL] [Abstract][Full Text] [Related]
17. Relation of red cell distribution width with CHA2DS2-VASc score in patients with nonvalvular atrial fibrillation.
Kurt M; Tanboga IH; Buyukkaya E; Karakas MF; Akçay AB; Sen N
Clin Appl Thromb Hemost; 2014 Oct; 20(7):687-92. PubMed ID: 23430929
[TBL] [Abstract][Full Text] [Related]
18. Pre-admission CHADS2, CHA2DS2-VASc, and R2CHADS2 Scores on Severity and Functional Outcome in Acute Ischemic Stroke with Atrial Fibrillation.
Tanaka K; Yamada T; Torii T; Furuta K; Matsumoto S; Yoshimura T; Takase K; Wakata Y; Nakashima N; Kira J; Murai H
J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):1629-35. PubMed ID: 25906940
[TBL] [Abstract][Full Text] [Related]
19. The Value of the CHADS
Yang HJ; Wang GJ; Shuai W; Shen CJ; Kong B; Huang H
J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104143. PubMed ID: 31477449
[TBL] [Abstract][Full Text] [Related]
20. The Refinement of Risk Stratification for Atrial Thrombus or Spontaneous Echo Contrast in Nonvalvular Atrial Fibrillation.
Ning W; Li Y; Ma C; Qiu L; Yu B
Int Heart J; 2017 Dec; 58(6):885-893. PubMed ID: 29151480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
